This paper conducts research on the established model and presents the main conclusions . Firstly, by separately considering the infectivity of each of the two infectious diseases and the infectivity of the population simultaneously infected with the two infectious diseases, the existence of three types of boundary equilibrium points is determined, as well as the existence of the interior equilibrium point when the parameters are under specific conditions. Then, the stability of the equilibrium points is analyzed. It is concluded that under different parameter conditions, the stability of the disease free equilibrium point can exhibit various scenarios, such as a stable node or a saddle-node, etc. For the boundary equilibrium points, the situation is more intricate,and a cusp may occur. The stability of the interior equilibrium point under specific conditions is also presented. Finally,the degeneracy of the equilibrium points is studied through the bifurcation theory.Mainly, the saddle-node bifurcation occurring at the interior equilibrium point is obtained, and when the infection rate of the first infectious disease, the infection rate of the second infectious disease, and the inf
The main aim to build models capable of simulating the spreading of infectious diseases is to control them. And along this way, the key to find the optimal strategy for disease control is to obtain a large number of simulations of disease transitions under different scenarios. Therefore, the models that can simulate the spreading of diseases under scenarios closer to the reality and are with high efficiency are preferred. In the realistic social networks, the random contact, including contacts between people in the public places and the public transits, becomes the important access for the spreading of infectious diseases. In this paper, a model can efficiently simulate the spreading of infectious diseases under random contacts is proposed. In this approach, the random contact between people is characterized by the random matrix with elements randomly generated and the spread of the diseases is simulated by the Markov process. We report an interesting property of the proposed model: the main indicators of the spreading of the diseases such as the death rate are invariant of the size of the population. Therefore, representative simulations can be conducted on models consist of small
In this study, we develop the mathematical model to understand the coupling between the spreading dynamics of infectious diseases and the mobility dynamics through urban transportation systems. We first describe the mobility dynamics of the urban population as the process of leaving from home, traveling to and from the activity locations, and engaging in activities. We then embed the susceptible-exposed-infectious-recovered (SEIR) process over the mobility dynamics and develops the spatial SEIR model with travel contagion (Trans-SEIR), which explicitly accounts for contagions both during travel and during daily activities. We investigate the theoretical properties of the proposed model and show how activity contagion and travel contagion contribute to the average number of secondary infections. In the numerical experiments, we explore how the urban transportation system may alter the fundamental dynamics of the infectious disease, change the number of secondary infections, promote the synchronization of the disease across the city, and affect the peak of the disease outbreaks. The Trans-SEIR model is further applied to the understand the disease dynamics during the COVID-19 outbrea
Univariate zero-inflated models are increasingly being used to account for excess zeros in spatio-temporal infectious disease counts. However, the multivariate case is challenging due to the need to account for correlations across space, time and disease in both the count and zero-inflated components of the model. We are interested in comparing the transmission dynamics of several co-circulating infectious diseases across space and time, where some of the diseases can be absent for long periods. We first assume there is a baseline disease that is well-established and always present in the region. The other diseases switch between periods of presence and absence in each area through a series of coupled Markov chains, which account for long periods of disease absence, disease interactions and disease spread from neighboring areas. Since we are mainly interested in comparing the diseases, we assume the cases of the present diseases in an area jointly follow an autoregressive multinomial model. We use the multinomial model to investigate whether there are associations between certain factors, such as temperature, and differences in the transmission intensity of the diseases. Inference
Reinforcement learning (RL), owing to its adaptability to various dynamic systems in many real-world scenarios and the capability of maximizing long-term outcomes under different constraints, has been used in infectious disease control to optimize the intervention strategies for controlling infectious disease spread and responding to outbreaks in recent years. The potential of RL for assisting public health sectors in preventing and controlling infectious diseases is gradually emerging and being explored by rapidly increasing publications relevant to COVID-19 and other infectious diseases. However, few surveys exclusively discuss this topic, that is, the development and application of RL approaches for optimizing strategies of non-pharmaceutical and pharmaceutical interventions of public health. Therefore, this paper aims to provide a concise review and discussion of the latest literature on how RL approaches have been used to assist in controlling the spread and outbreaks of infectious diseases, covering several critical topics addressing public health demands: resource allocation, balancing between lives and livelihoods, mixed policy of multiple interventions, and inter-regional
It was observed that the number of cases and deaths for infectious diseases were associated with heavy-tailed power law distributions such as the Pareto distribution. While Pareto distribution was widely used to model the cases and deaths of infectious diseases, a major limitation of Pareto distribution is that it can only fit a given data set beyond a certain threshold. Thus, it can only model part of the data set. Thus, we proposed some novel discrete composite distributions with Pareto tails to fit the real infectious disease data. To provide necessary statistical inference for the tail behavior of the data, we developed a hypothesis testing procedure to test the tail index parameter. COVID-19 reported cases in Singapore and monkeypox reported cases in France were analyzed to evaluate the performance of the newly created distributions. The results from the analysis suggested that the discrete composite distributions could demonstrate competitive performance compared to the commonly used discrete distributions. Furthermore, the analysis of the tail index parameter can provide great insights into preventing and controlling infectious diseases.
We introduce a system of differential equations to assess the impact of (self-)quarantine of symptomatic infectious individuals on disease dynamics. To this end we depart from using the classic bilinear infection process, but remain still within the framework of the mass-action assumption. From the mathematical point of view our model is interesting due to the lack of continuous differentiability at disease free steady states, which implies also that the basic reproductive number cannot be computed following established approaches for certain parameter values. However, we parametrise our mathematical model using published values from the COVID-19 literature, and analyse the model simulations. We also contrast model simulations against publicly available COVID-19 test data focusing on the first wave of the pandemic during March - July 2020 in the UK. Our simulations indicate that actual peak case numbers might have been as much as 200 times higher than the reported positive test cases during the first wave in the UK. We find that very strong adherence to self-quarantine rules yields (only) a reduction of 22$\%$ of peak numbers and delays the onset of the peak by approximately 30-35
The annual occurrence of many infectious diseases remains a constant burden to public health systems. The seasonal patterns in respiratory disease incidence observed in temperate regions have been attributed to the impact of environmental conditions on pathogen survival. A model describing the transmission of an infectious disease by means of a pathogenic state capable of surviving in an environmental reservoir outside of its host organism is presented in this paper. The ratio of pathogen lifespan to the duration of the infectious disease state is found to be a critical parameter in determining disease dynamics. The introduction of a seasonally forced pathogen inactivation rate identifies a time delay between peak pathogen survival and peak disease incidence. The delay is dependent on specific disease parameters and, for influenza, decreases with increasing reproduction number. The observed seasonal oscillations are found to have a period identical to that of the seasonally forced inactivation rate and which is independent of the duration of infection acquired immunity
Artificial Intelligence (AI) and infectious diseases prediction have recently experienced a common development and advancement. Machine learning (ML) apparition, along with deep learning (DL) emergence, extended many approaches against diseases apparition and their spread. And despite their outstanding results in predicting infectious diseases, conflicts appeared regarding the types of data used and how they can be studied, analyzed, and exploited using various emerging methods. This has led to some ongoing discussions in the field. This research aims not only to provide an overview of what has been accomplished, but also to highlight the difficulties related to the types of data used, and the learning methods applied for each research objective. It categorizes these contributions into three areas: predictions using Public Health Data to prevent the spread of a transmissible disease within a region; predictions using Patients' Medical Data to detect whether a person is infected by a transmissible disease; and predictions using both Public and patient medical data to estimate the extent of disease spread in a population. The paper also critically assesses the potential of AI and out
Urban areas with larger and more connected populations offer an auspicious environment for contagion processes such as the spread of pathogens. Empirical evidence reveals a systematic increase in the rates of certain sexually transmitted diseases (STDs) with larger urban population size. However, the main drivers of these systemic infection patterns are still not well understood, and rampant urbanization rates worldwide makes it critical to advance our understanding on this front. Using confirmed-cases data for three STDs in US metropolitan areas, we investigate the scaling patterns of infectious disease incidence in urban areas. The most salient features of these patterns are that, on average, the incidence of infectious diseases that transmit with less ease-- either because of a lower inherent transmissibility or due to a less suitable environment for transmission-- scale more steeply with population size, are less predictable across time and more variable across cities of similar size. These features are explained, first, using a simple mathematical model of contagion, and then through the lens of a new theory of urban scaling. These theoretical frameworks help us reveal the lin
Understanding dynamics of an infectious disease helps in designing appropriate strategies for containing its spread in a population. Recent mathematical models are aimed at studying dynamics of some specific types of infectious diseases. In this paper we propose a new model for infectious diseases spread having susceptible, infected, and recovered populations and study its dynamics in presence of incubation delays and relapse of the disease. The influence of treatment and vaccination efforts on the spread of infection in presence of time delays are studied. Sufficient conditions for local stability of the equilibria and change of stability are derived in various cases. The problem of global stability is studied for an important special case of the model. Simulations carried out in this study brought out the importance of treatment rate in controlling the disease spread. It is observed that incubation delays have influence on the system even under enhanced vaccination. The present study has clearly brought out the fact that treatment rate in presence of time delays would contain the disease as compared to popular belief that eradication can only be done through vaccination.
Infectious diseases are a significant threat to human society which was over sighted before the incidence of COVID-19, although according to the report of the World Health Organisation (WHO) about 4.2 million people die annually due to infectious disease. Due to recent COVID-19 pandemic, more than 2 million people died during 2020 and 96.2 million people got affected by this devastating disease. Recent research shows that applying individual interactions and movements data could help managing the pandemic though modelling the spread of infectious diseases on social contact networks. Infectious disease spreading can be explained with the theories and methods of diffusion processes where a dynamic phenomena evolves on networked systems. In the modelling of diffusion process, it is assumed that contagious items spread out in the networked system through the inter-node interactions. This resembles spreading of infectious virus, e.g. spread of COVID-19, within a population through individual social interactions. The evolution behaviours of the diffusion process are strongly influenced by the characteristics of the underlying system and the mechanism of the diffusion process itself. Thus
The integration of empirical data in computational frameworks to model the spread of infectious diseases poses challenges that are becoming pressing with the increasing availability of high-resolution information on human mobility and contacts. This deluge of data has the potential to revolutionize the computational efforts aimed at simulating scenarios and designing containment strategies. However, the integration of detailed data sources yields models that are less transparent and general. Hence, given a specific disease model, it is crucial to assess which representations of the raw data strike the best balance between simplicity and detail. We consider high-resolution data on the face-to-face interactions of individuals in a hospital ward, obtained by using wearable proximity sensors. We simulate the spread of a disease in this community by using an SEIR model on top of different mathematical representations of the contact patterns. We show that a contact matrix that only contains average contact durations fails to reproduce the size of the epidemic obtained with the high-resolution contact data and also to identify the most at-risk classes. We introduce a contact matrix of pro
Infectious disease models can be of great use for understanding the underlying mechanisms that influence the spread of diseases and predicting future disease progression. Modeling has been increasingly used to evaluate the potential impact of different control measures and to guide public health policy decisions. In recent years, there has been rapid progress in developing spatio-temporal modeling of infectious diseases and an example of such recent developments is the discrete time individual-level models (ILMs). These models are well developed and provide a common framework for modeling many disease systems, however, they assume the probability of disease transmission between two individuals depends only on their spatial separation and not on their spatial locations. In cases where spatial location itself is important for understanding the spread of emerging infectious diseases and identifying their causes, it would be beneficial to incorporate the effect of spatial location in the model. In this study, we thus generalize the ILMs to a new class of geographically-dependent ILMs (GD-ILMs), to allow for the evaluation of the effect of spatially varying risk factors (e.g., education
Humans, domestic animals, orchard crops, and ornamental plants are commonly treated with antibiotics in response to bacterial infection. By curing infectious individuals, antibiotic therapy might limit the spread of contagious disease among hosts. But an antibiotic`s suppression of within-host pathogen density might also reduce the probability that the host is otherwise removed from infectious status prior to therapeutic recovery. When rates of both recovery via treatment and other removal events (e.g., isolation or mortality) depend directly on within-host pathogen density, antibiotic treatment can relax the overall removal rate sufficiently to increase between-host disease transmission. To explore this dependence, a deterministic within-host dynamics drives the infectious host's time-dependent probability of disease transmission, as well as the probabilistic duration of the infectious period. At the within-host scale, the model varies (1) inoculum size, (2) bacterial self-regulation, (3) the time between infection and initiation of therapy, and (4) antibiotic efficacy. At the between-host scale the model varies (5) the size/susceptibility of groups randomly encountered by an infe
A better characterization of the early growth dynamics of an epidemic is needed to dissect the important drivers of disease transmission. We introduce a 2-parameter generalized-growth model to characterize the ascending phase of an outbreak and capture epidemic profiles ranging from sub-exponential to exponential growth. We test the model against empirical outbreak data representing a variety of viral pathogens and provide simulations highlighting the importance of sub-exponential growth for forecasting purposes. We applied the generalized-growth model to 20 infectious disease outbreaks representing a range of transmission routes. We uncovered epidemic profiles ranging from very slow growth (p=0.14 for the Ebola outbreak in Bomi, Liberia (2014)) to near exponential (p>0.9 for the smallpox outbreak in Khulna (1972), and the 1918 pandemic influenza in San Francisco). The foot-and-mouth disease outbreak in Uruguay displayed a profile of slower growth while the growth pattern of the HIV/AIDS epidemic in Japan was approximately linear. The West African Ebola epidemic provided a unique opportunity to explore how growth profiles vary by geography; analysis of the largest district-level
We construct a set of new epidemiological thresholds to address the general problem of spreading and containment of a disease with influx of infected individuals when the classic $\mathcal R_0$ is no longer meaningful. We provide analytical properties of these indices and illustrate their usefulness in a compartmental model of COVID-19 with data taken from Chile showing a good predictive potential when contrasted with the recorded disease behaviour. This approach and the associated analytical and numerical results allow us to quantify the severity of an immigration of infectious individuals into a community, and identification of the key parameters that are capable of changing or reversing the spread of an infectious disease in specific models.
Infectious disease outbreaks recapitulate biology: they emerge from the multi-level interaction of hosts, pathogens, and their shared environment. As a result, predicting when, where, and how far diseases will spread requires a complex systems approach to modeling. Recent studies have demonstrated that predicting different components of outbreaks--e.g., the expected number of cases, pace and tempo of cases needing treatment, demand for prophylactic equipment, importation probability etc.--is feasible. Therefore, advancing both the science and practice of disease forecasting now requires testing for the presence of fundamental limits to outbreak prediction. To investigate the question of outbreak prediction, we study the information theoretic limits to forecasting across a broad set of infectious diseases using permutation entropy as a model independent measure of predictability. Studying the predictability of a diverse collection of historical outbreaks--including, chlamydia, dengue, gonorrhea, hepatitis A, influenza, measles, mumps, polio, and whooping cough--we identify a fundamental entropy barrier for infectious disease time series forecasting. However, we find that for most di
Effective public health decisions require early reliable inference of infectious disease properties. In this paper we assess the ability to infer infectious disease attributes from population-level stochastic epidemic trajectories. In particular, we construct stochastic Kermack-McKendrick model trajectories, sample them with and without observational error, and evaluate inversions for the population mean infectiousness as a function of time since infection, the infection duration distribution, and its complementary cumulative distribution, the infection survival distribution. Based on an integro-differential equation formulation we employ a natural regression approach to fit the corresponding integral kernels and show that these disease attributes are recoverable from both multi-trajectory inversions and regularized single trajectory inversions. Moreover, we demonstrate that the infection duration distribution (or alternatively the infection survival distribution) and population mean infectiousness kernel recovered can be used to solve for the individual infectiousness profile, the infectiousness of an individual over the duration of their infection, assuming that individual infect
Over the past 50 years, the advancements in medical and health research have radically changed the epidemiology of health conditions in neonates, children, and adolescents; and clinical research has on the whole, moved forward. However, large sections of the pediatric community remain vulnerable and underserved, by clinical research. One reason for this is the fact that most pediatric diseases are also rare diseases (i.e., they fit the EU definition of a rare condition, by affecting no more than 5 in 10,000 individuals), and indeed the majority of conditions under this umbrella heading are in fact much rarer, affecting fewer than 1 in 100,000. Rare pediatric diseases incur particular challenges, both in terms of actually conducting clinical trials but also planning trials (and indeed, stimulating the preclinical research and knowledge generation necessary to embark on clinical trials in the first place). The pediatric regulation and orphan regulation (covering rare diseases) were introduced to address the complexities in research and development of medicines specifically for children and for people living with a rare disease, respectively. The regulations have been reasonably effec